Clinical Trial Update: KISS Study: Kinase Inhibition With Sprycel Start up [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for a study evaluating Sprycel (dasatinib) in Chronic Myeloid Leukemia led by the University of Auckland; current status is unkn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Sprycel (dasatinib)

Snippet

Sponsor: University of Auckland, New Zealand | Conditions: Chronic Myeloid Leukemia | Phase 2 | Status: UNKNOWN